Answers are grounded in this paper and cite their sources.
Aging is a major risk factor for bullous pemphigoid (BP), but aging-induced cutaneous self-tolerance failure remains largely unclear. We examined skin and sera from mice across an age range using direct immunofluorescence (DIF), indirect immunofluorescence (IIF), immunoblotting against recombinant proteins of the dermal–epidermal junction (DEJ), and super-resolution microscopy. Although aged mice developed no blisters or inflammation, they displayed age-dependent linear IgM deposits at the DEJ. Circulating IgM targeted both epidermal and dermal DEJ components and comprised two specificities: age-acquired anti–type XVII collagen (COL17, autoantigen in BP) IgM and lifelong anti–type VII collagen (COL7, autoantigen in epidermolysis bullosa acquisita) IgM. Anti-COL7 IgM persisted across diverse immunopathological models and was reduced in B-1a–deficient mice, supporting a natural antibody origin. We propose a model in which lifelong anti-COL7 natural IgM coexists with aging-driven emergence of anti-COL17 IgM, suggesting a subclinical pre-BP state.
No takes yet. Share an insight, caveat, or question.
Shiiya et al. (2026) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: